Skip to content

Clinical trials

Phase 1/2 Inflammation trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 1/2 Country / region: Canada Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20172
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Atara Biotherapeutics1
Igy Nutrition, LLC1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Montreal Heart Institute1
University of Saskatchewan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation5
Agnosia1
Autoimmune Diseases1
Cardiovascular Diseases1
Demyelinating Diseases1
Epstein-Barr Virus Infections1
Multiple Sclerosis1
Multiple Sclerosis, Chronic Progressive1
Muscle Weakness1
Pain1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.